Diabetes Mellitus Part 2 Flashcards

1
Q

Diabetes is a

A

disease of hyperglycemia due to insulin loss or resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

T1DM usually seen in

A

young and lean pts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

T2DM is usually seen in

A

older & overwt/ obese pts
pts with Fhx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

DM dx

A

fasting plasma glucose (HbA1c*, random glucose, OGTT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Regardless of type of DM, management starts with

A

diet and exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Type 1 DM is when

A

insulin production is absent due to autoimmune pancreatic beta cell destruction
usually develops in childhood/ adolescence, may develop in adults (latent autoimmune diabetes of adulthood, initially appears like T2DM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

T1DM pathophysiology

A

T-cell mediated response resulting in beta-cell destruction (insulitis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

T1DM presentation

A

sx hyperglycemia (random glucose > 200)
may present in diabetic ketoacidosis (DKA)
polyuria, polydipsia, dehydration, nausea, unexplained wt loss, weakness, blurry vision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

T1DM workup/dx

A

random serum glucose
fasting glucose
glucose tolerance testing
urinalysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

T1DM treatment

A

insulin induction (lifetime insulin therapy)
electrolyte management
diet/ exercise - consult nutritionist
consult endo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

T1DM treatment: Insulin

A

dose based on wt
basal insulin (single injection)
Pre-prandial (divided doses given before a meal, each does is determined by estimating carbohydrate content of meal, insulin to carb ratio = 1:20 insulin sensitive to 1:5 insulin resistant)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

T1DM glycemia control HgA1c should be

A

less than or equal to 7 for most

individualized on basis of age, comorbidities, duration of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

T1DM treatment - Insulin adverse reactions

A

Lipoatrophy - loss of fat at injection site; may allow for incidental intramuscular injection
Hypertrophy - increase in fat mass at site, leads to erratic insulin absorption
Resistance - require larger amounts of insulin to get desired effect, due to antibody formation

need to rotate sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

DKA can result in

A

Cerebral Edema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

DKA diagnostic criteria

A

Diabetic (Glucose > 200)
Ketonuria
Acidosis (pH < 7.3)
venous bicarb < 15

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

T1DM Complications - DKA IV fluid management

A

patient WITH signs of shock (tachycardia, hypotension, poor profusion, AMS) = bolus 2-3 liters of Normal saline -> STAT

patient WITHOUT signs of shock = Normal saline over 1 hour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

T1DM Complications - DKA steps 1-3:

A

1 - fluid replacement (approx fluid loss 6-9 L in DKA)
2 - electrolyte replacement (correct hypokalemia, if you start insulin therapy before electrolyte replacement you will worsen hypokalemia - cause of morbidity/ mortality from cardiac arrhythmias and resp muscle weakness, correct serum sodium)
3 - insulin drip (GO SLOW, goal is to close anion gap acidosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Once DKA has resolved:
pH >
glucose < or equal to
Bicarb level is > or equal to

A

pH > 7.3
Glucose < or equal 200 mg/dL
Bicarbonate > or equal to 18 mEq/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

once levels achieved, oral fluids tolerated, start –>

A

start insulin regimen that includes intermediate or long-acting insulin AND short or rapid-acting insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Leading cause of death in children presenting in DKA

A

Cerebral Edema

21
Q

Suspect Cerebral Edema with DKA when pt presents with

A

sudden HA with neurological deterioration (altered LOC and Lethargy) - usually within 4-12 hours treatment onset

22
Q

The ________ the patient the _______ you go (pertaining to insulin)

A

sicker, slower
no insulin bolus/ lower insulin drip
judicious use of IV fluids

23
Q

What is insulin based off?

A

wt
0.5 units/kg/day

24
Q

The more units per mL the ______ it will be absorbed

25
How is insulin usually administered?
SubQ usually in the abdomen
26
T2DM etiology
adult onset or non-insulin dependent DM Glucose intolerance - insulin secretion inadequate to overcome resistance insulin levels are very high, esp early in the disease, later insulin production may fall, further exacerbating hyperglycemia
27
T2DM is when
hyperglycemia develops when insulin secretion can no longer compensate for insulin resistance
28
Hyperglycemia may cause
impairment of insulin secretion or desensitize beta cells and cause beta cell dysfunction (glucose toxicity) or both
29
Changes typically takes years to develop the presence of insulin resistance --> usually ______ years before clinical diagnosis of DM
4-7 years
30
What are two determinants of insulin resistance
obesity wt gain (adipose tissue functions as an endocrine organ; releases multiple factors that favorable and adversely influence glucose metabolism)
31
T2DM risk factors
age greater than or equal to 45 overwt or obesity FHx DM PCOS Hx HTN Dyslipidemia Gestational diabetes mellitus
32
DKA provocation
infection infarction (CVA or MI) iatrogenic surgery intoxication initial onset of dx not good insulin management (gave themselves too little or none at all)
33
Signs and symptoms of DM
hyperglycemia: polyuria, polydipsia progress to orthostatic hypotension, dehydration (severe dehydration: weakness, fatigue, mental status changes) polyphagia wt loss, n/v, blurred vision, hx of bacterial/ fungal infections
34
DM diagnostic criteria:
fasting plasma glucose > 126 mg/dL random glucose > 200 mg/dL with sx of hyperglycemia or hyperglycemia crisis 2-hr plasma glucose > 200 mg/dL during 76 g OGTT
35
Pre-diabetic dx criteria:
FPG > 100-125 mg/dL 2-hr OGTT plasma glucose of 140-199 mg/dL HbA1c 5.7-6.4%
36
_______ is not recommended for diagnosing T1DM or gestational DM
HbA1c
37
T2DM initial pharmaceutical treatment/management:
preferred - metformin additional medications are added in stepwise pattern - GLP-1, SGLT2 inhibitors preferred over insulin inless sx hyperglycemia
38
T2DM management:
Blood Pressure Management if > 120/80 lifestyle management ACE/ARB if > 160/100 add thiazide or dihydropyridine CCB (amlodipine, diltiazem, nifedipine) Lipid Management: statins, Omega 3 fish oils
39
Maturity Onset DM of Youth (MODY) is
usually seen in adolescents with obesity: Peripheral insulin sensitivity 50% overwt and obese children > 10 years should be screened (include pancreatic autoantibodies to rule out T1DM)
40
MODY treatment
lifestyle management consider metabolic surgery if fails multidisciplinary team needed: endo, nutrition, behavioral health
41
Hyperosmotic Hyperglycemic Nonketotic Syndrome (HHNK) is
metabolic complication characterized by severe hyperglycemia, extreme dehydration, hyperosmolar plasma, and altered consciousness often occurs in T2DM - think 'type 2 DKA'
42
Treatment of HHNK
IV saline solution and insulin
43
Complications of HHNK
coma seizures death
44
Presentation of HHNK
primary sx = altered mental status varies from confusion or disorientation to coma usually extreme dehydration with or without prerenal azotemia, hyperglycemia, hyperosmolality
45
Unlike DKA, HHNK can lead to
focal or generalized seizures and transient hemiplegia may occur
46
HHNK dx
blood glucose level - elevated serum osmolarity urine tested for ketones arterial pH usually > 7.3
47
Treatment for HHNK
IV isotonic saline 15-20 mL/kg/hour Correction of any hypokalemia IV insulin (if potassium is less than or equal to 3.3 mEq/L)
48
T2DM final treatment plan
routine follow up and lab testing oral agents with/without insulin ACE/ARB (renal vs HTN dosing) Statin (pending ASCVD risk) annual flu shot and pneumonia vaccine